GLP-2 TRZ 100mg Peptides
Precision you can count on—built for research environments that demand consistent, reproducible peptide performance.
The Primavora GLP-2 TRZ 100mg lyophilized peptide vial is formulated for laboratory use where control, clarity, and traceability matter. This neutral, unflavored powder delivers a total of 100mg of GLP-2 TRZ in a stable freeze-dried format designed for dependable handling and method development. As part of our GLP peptide collection, this vial aligns with the expectations of modern research teams seeking purity, consistency, and transparent documentation from a USA-based source.
- Each vial contains 100mg of GLP-2 TRZ, a GLP-class research analog commonly evaluated in receptor-binding studies, gastrointestinal epithelium models, permeability and barrier assessments, and in vitro assay optimization where peptide stability and solubility characteristics are critical.
The lyophilized format supports stability during storage and controlled preparation at the bench. Researchers value the clean, uniform appearance and reliable dissolution characteristics that aid in creating precise dilution series, aliquoting protocols, and repeatable experimental setups. The presentation is engineered for laboratories that prioritize aseptic technique, careful documentation, and consistent results across replicates and time.
Every GLP-2 TRZ vial from Primavora reflects a disciplined approach to quality. Batches are produced in the United States under controlled conditions, with lot-level traceability and documentation designed to support internal QA workflows. Each lot is batch-tested for identity and purity with analytical methods such as HPLC and LC-MS to confirm composition and integrity. Packaging is handled in clean, controlled environments to protect the material from unnecessary variability, and tamper-evident measures help ensure chain-of-custody confidence from our facility to your bench.
Primavora is committed to rigor, transparency, and the standards that serious research requires. Certificates of Analysis are available, and each vial is labeled with clear identifiers to support inventory control and audit readiness. This material is intended strictly for laboratory research use only. It is not for human or animal consumption, medical, diagnostic, or therapeutic use. Always follow institutional SOPs for storage, handling, and disposal. With Primavora, you can rely on a focused, research-first peptide supply—where quality comes first and standards are non-negotiable.
- Most orders ship within 24 hours and arrive within 3 to 5 days of leaving our warehouse.
- Shipping is free on orders of $99+ (except Hawaii and Alaska).
- All orders ship in discreet packaging via USPS Ground Advantage mail.
Delivery restrictions vary by state.
This Product Contains
Customer Reviews
There are no reviews yet. Be the first to write a review!
Frequently Asked Questions
What is GLP-2 TRZ?
GLP-2 TRZ appears to be a supplier-specific name for a GLP-2-oriented research compound or analog. Because the 'TRZ' suffix is not a universal scientific naming standard, the exact structure should be confirmed from the product specification or COA. Conservative site copy should therefore describe it as a GLP-2-pathway laboratory compound.
What is GLP-2 TRZ typically studied for?
GLP-2-related compounds are usually studied for intestinal growth, mucosal integrity, nutrient-absorption physiology, and gut-repair signaling. The safest FAQ wording is to explain those GLP-2 research themes while noting that the exact behavior of this product depends on the specific analog being sold.
What are GLP peptides?
GLP peptides — glucagon-like peptides — are a family of peptides derived from the post-translational processing of the proglucagon precursor. The main members are GLP-1 and GLP-2, both of which are produced primarily by intestinal L-cells. GLP-1 is studied in the context of insulin secretion, glucose metabolism, and appetite signaling, while GLP-2 is investigated for its role in intestinal epithelial biology.
A number of synthetic analogs and research compounds exist in this category, including semaglutide-class and tirzepatide-class sequences, as well as dual- and triple-agonist research peptides. All GLP peptide products from Prima Vora are lyophilized research materials intended solely for in vitro laboratory investigation.
How do GLP analogs differ from native GLP hormones?
Native GLP-1 has a very short half-life in plasma — on the order of a few minutes — because it is rapidly degraded by the enzyme dipeptidyl peptidase-4 (DPP-4). GLP analogs are engineered peptides that modify the native sequence or attach additional groups such as fatty acid chains, in order to resist DPP-4 degradation, extend half-life, and optimize receptor binding.
This extended stability is what makes GLP analogs useful in research as practical tools for studying the GLP-1 and related receptor systems in controlled experiments. The analogs differ from native GLP hormones primarily in their pharmacokinetic profile and, in some cases, their receptor selectivity across the GLP-1, GIP, and glucagon receptor families.
What is the difference between GLP-1, GLP-2, and GLP-3 in research?
GLP-1 and GLP-2 are both produced from the proglucagon precursor. GLP-1 is studied in connection with the GLP-1 receptor, insulin secretion, and appetite signaling, while GLP-2 is studied primarily in connection with the GLP-2 receptor and intestinal epithelial biology. The two peptides share a common precursor but have different receptor targets and research focuses.
GLP-3 is not a classical endogenous peptide in the same way as GLP-1 and GLP-2. The term is sometimes used as a research label for engineered or triple-agonist peptides that combine activity at GLP-1, GIP, and glucagon receptors in a single molecule. In this sense, GLP-3 in research usually refers to a designed multi-target compound rather than a naturally occurring hormone.
